Registered entities
Cerulean Pharma Inc.
Reg. No. 204139823United Kingdom
Innovation
48 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 9,869 times.
| Year | Filings |
|---|---|
| 2012 | 19 |
| 2013 | 23 |
| 2014 | 28 |
| 2015 | 23 |
| 2016 | 16 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
Investor mix
7 investors on record; lead investors include Bessemer Venture Partners, Lilly Ventures, Lux Capital, Polaris Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 1 | 14% |
